Validity of sudden gains in acute phase treatment of depression.
The authors examined the validity of sudden gains identified with T. Z. Tang and R. J. DeRubeis's (1999) method in 2 clinical data sets that involved treatment of major depressive disorder (N=227). Sudden gains replicated among self- and clinician reports of depressive symptoms and predicted better psychosocial functioning at the acute phase treatment end point, in support of their validity. However, sudden gains occurred with roughly the same moderate frequency in pill placebo and pharmacotherapy with clinical management as in cognitive therapy. Furthermore, sudden gains predicted more depressive symptoms and negative failure attributions in longitudinal follow-up of responders to acute phase cognitive therapy. On the basis of these findings, the authors conceptualize sudden gains as one of several possible patterns of acute phase treatment response.
Vittengl
Jeffrey R
JR
Division of Social Science, Truman State University, Kirksville, MO 63501-4221, USA. vittengl@truman.edu
Clark
Lee Anna
LA
Jarrett
Robin B
RB
D000208:Acute Disease; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D001290:Attitude; D001364:Awareness; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007389:Internal-External Control; D007398:Interpersonal Relations; D008297:Male; D010043:Outcome and Process Assessment, Health Care; D010553:Personality Development; D010555:Personality Inventory / Q000706:statistics & numerical data; D010624:Phenelzine / Q000627:therapeutic use; D012008:Recurrence; D015203:Reproducibility of Results; D012647:Self-Assessment; D012917:Social Adjustment; D016896:Treatment Outcome
D000928:Antidepressive Agents; D010624:Phenelzine